Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling

Huihui Li1, Yue Wang2

  • 1Department of Digestive System, Beilun People's Hospital, Ningbo, Zhejiang, China (mainland).

Insights

Long noncoding RNA MIR22HG suppresses gastric cancer progression. Low MIR22HG levels correlate with reduced survival, and its upregulation inhibits tumor growth and spread by attenuating NOTCH2 signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are key regulators in human diseases, including cancers.
  • LncRNA MIR22HG is known to inhibit progression in endometrial carcinoma, lung cancer, and hepatocellular carcinoma.
  • The specific role of MIR22HG in gastric cancer remains largely uncharacterized.

Purpose of the Study:

  • To investigate the functional role of lncRNA MIR22HG in gastric cancer.
  • To determine the relationship between MIR22HG expression and patient survival.
  • To elucidate the molecular mechanism underlying MIR22HG's effect on gastric cancer progression, particularly its interaction with NOTCH2 signaling.

Main Methods:

  • Analysis of MIR22HG expression in 43 gastric cancer tissues and 21 adjacent normal tissues.
  • Correlation of MIR22HG expression with 5-year overall survival rates.
  • In vitro studies using gastric cancer cell lines (AGS, MKN-45) involving overexpression and knockdown of MIR22HG and NOTCH2.
  • Assessment of cell proliferation (CCK-8 assay), migration, and invasion (Transwell assay).
  • Gene and protein expression analysis using qRT-PCR and Western blot.

Main Results:

  • MIR22HG expression was significantly decreased in gastric cancer tissues and cells compared to normal controls.
  • Lower MIR22HG expression was associated with a significantly lower 5-year overall survival rate.
  • MIR22HG upregulation inhibited proliferation, migration, and invasion in gastric cancer cells, while its downregulation promoted these processes.
  • MIR22HG negatively regulated NOTCH2 signaling, with MIR22HG silencing increasing HEY1 and nuclear NOTCH2 expression.
  • NOTCH2 silencing suppressed the proliferation, migration, and invasion of gastric cancer cells.

Conclusions:

  • LncRNA MIR22HG acts as a tumor suppressor in gastric cancer.
  • MIR22HG suppresses gastric cancer progression by attenuating the NOTCH2 signaling pathway.
  • MIR22HG may serve as a potential prognostic biomarker and therapeutic target for gastric cancer.

Related Concept Videos

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries07:35

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries

Here, we present a protocol demonstrating the installation and use of a bioinformatics pipeline to analyze chimeric RNA sequencing data used in the study of in vivo RNA:RNA...
1.1K
Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue06:36

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue

Here, we present a protocol of elastic staining to identify elastic fibers in pT3N0M0 gastric cancer tissues on formalin-fixed, paraffin-embedded sections. Subsequently, we describe a method to determine whether tumor cells invade beyond the elastic...
7.4K
Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder09:29

Signal Attenuation as a Rat Model of Obsessive Compulsive Disorder

The goal of the protocol described in this paper is to induce compulsive-like behavior in rats for the study of obsessive-compulsive disorder (OCD). This behavior is precipitated by attenuating a signal indicating that a lever-press response was effective in producing...
15.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.1K